ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/05/2026
Back to search
Official data from USPTO
AVAXZIPEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AVAXZIPEN
ST13
US500000079388905Class
5, 10, 42
Filing
79388905
Registration
7656600
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
03/31/2023
Registration date
01/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
PEREZ, STEVEN M
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
AVAXMED LIMITED
AVAXZIPEN LIMITED
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalbiopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceuticalbiopharmaceutical and veterinary preparations and substances for the treatment of or protection against viralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substancesnamely for the treatment of infectious and autoimmune diseases; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical usemixed biological preparations for the prevention and treatment of infectious and autoimmune diseases; biologicalchemical and biochemical reagents for medical use; contraceptive preparations and substancesoralchemical and parenteral based contraceptives
Class 10
Surgical apparatus and instruments; medicaldental and veterinary apparatus and instrumentsinjection and infusion devices for administering pharmaceuticalbiopharmaceutical and veterinary preparations; drug delivery devices sold emptyinjection devices; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations parenterally; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intradermal tissue; actuator devices being injection devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devicesdrug cassettes sold empty; drug delivery devicesnamely medical injectorsneedle-free injectorsinjectors with needlesall sold empty; drug delivery devicessold emptymedical injectorsneedle-free injectors and parts and fittings therefore; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices for injecting pharmaceuticalbiopharmaceutical and veterinary preparations parenterally; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for use in drug delivery devicesnamely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceuticalbiopharmaceutical and veterinary preparations into intramuscular tissue; pre-loaded drug cassettes for use in drug delivery devices to contain pharmaceutical and biopharmaceutical preparations and substances for therapeuticprophylactic and diagnostic use; Structural parts and fittings for all the aforesaid goods
Class 42
Medical and veterinary research and product development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; Product development of pharmaceutical and biopharmaceutical delivery systems; Pharmaceutical and biopharmaceutical product developmentnamely research and formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; Product testing services for medical and veterinary devices and products; provision of information relating to product development and testing; Consulting services in the field of product development and testing
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/23/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/05/2025
FIMP
FINAL DISPOSITION PROCESSED
08/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/26/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/22/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2024
PUBO
PUBLISHED FOR OPPOSITION
12/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/27/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2024
RFNT
REFUSAL PROCESSED BY IB
04/16/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/25/2024
RFRR
REFUSAL PROCESSED BY MPU
03/25/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/02/2024
CNRT
NON-FINAL ACTION WRITTEN
03/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/16/2024
DOCK
ASSIGNED TO EXAMINER
02/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2024
Continuous trademark protection
Get notified about every new filing that threatens AVAXZIPEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.